Hemorai

Curated by Signal

Developer of non-invasive postpartum hemorrhage detection device

Overview

Hemorai is developing a non-invasive postpartum hemorrhage detection device. The device combines the optical spectroscopy technology and uses artificial intelligence that measures hematocrit levels from the bleeding mother.

Key facts

Founded: 2019
Headquarters: Austin, United States
Stage: Sign up to view
Industry: Life Sciences Technology

Contact

Primary office: Sign up to view
Phone: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

Health Heritage
Clinical decision support for personalized risk assessment for major inheritable cancers.
Life Sciences TechnologyChicago, United States
Identifeye Health
Developer of a non-invasive test to detect health conditions through the eyes
Life Sciences TechnologyGuilford, United States
Freedom Innovations
Lower limb prosthetic solutions for amputees
Life Sciences TechnologyIrvine, United States

About Hemorai

What does Hemorai do?

Hemorai is developing a non-invasive postpartum hemorrhage detection device.

Where is Hemorai headquartered?

Hemorai is headquartered in Austin, United States.

When was Hemorai founded?

Hemorai was founded in 2019.

Which sector is Hemorai in?

Hemorai operates in Life Sciences Technology.

Who are Hemorai's competitors?

Companies similar to Hemorai include Health Heritage, Identifeye Health, and Freedom Innovations.